Agenus to report fourth quarter and year end 2015 financial results
on march 3, 2016; conference call to follow
Lexington, mass.--(business wire)--agenus inc. (nasdaq: agen), an immuno-oncology company developing checkpoint modulator antibodies and cancer vaccines, will release its fourth quarter and year end 2015 financial results before the market opens on thursday, march 3, 2016. agenus executives will host a conference call at 11:00 a.m. et the same day. to access the live call, dial 1-888-799-5016 (u.s.) or 1-704-908-0465 (international) and refer to conference id number 59317465. the call will also be webcast and will be accessible from the company’s website at www.agenusbio.com/webcast. a replay will be available on the company’s website approximately two hours after the call and will remain available for 60 days. the replay number is 1-855-859-2056 (u.s.) 1-404-537-3406 (international), conference id number 59317465. about agenus agenus is an immunotherapy company focused on the discovery and development of revolutionary new treatments that engage the body’s immune system to benefit patients suffering from cancer. by combining multiple powerful platforms, agenus has established a highly integrated approach to target identification and validation, and for the discovery, development and manufacturing of monoclonal antibodies that modulate targets of interest. the company’s broad portfolio of novel checkpoint modulator and other immuno-modulatory monoclonal antibodies, vaccines and adjuvants, work in combination to provide the opportunity to create best-in-class therapeutic regimens. agenus’ heat shock protein-based vaccine, prophage™, has successfully completed phase 2 studies in newly-diagnosed glioblastoma. the company is collaborating with merck and incyte to discover and develop multiple checkpoint modulators. for more information, please visit www.agenusbio.com; information that may be important to investors will be routinely posted on our website. forward-looking statement this press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the federal securities laws, including statements regarding agenus’ anticipated timing for releasing its fourth quarter and year end 2015 financial results. these forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially. these risks and uncertainties include, among others, the factors described under the risk factors section of agenus’ form 10-q filed with the securities and exchange commission on november 4, 2015. agenus cautions investors not to place considerable reliance on the forward-looking statements contained in this release. these statements speak only as of the date of this press release, and agenus undertakes no obligation to update or revise the statements, other than to the extent required by law. all forward-looking statements are expressly qualified in their entirety by this cautionary statement.
AGEN Ratings Summary
AGEN Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission